Does low-density lipoprotein cholesterol induce inflammation? If so, does it matter? Current insights and future perspectives for novel therapies
出版年份 2019 全文链接
标题
Does low-density lipoprotein cholesterol induce inflammation? If so, does it matter? Current insights and future perspectives for novel therapies
作者
关键词
-
出版物
BMC Medicine
Volume 17, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-11-01
DOI
10.1186/s12916-019-1433-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The cost-effectiveness of canakinumab for secondary prevention of cardiovascular disease: The Australian healthcare perspective
- (2019) Ella Zomer et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Cost-effectiveness of Canakinumab for Prevention of Recurrent Cardiovascular Events
- (2019) Thomas S. G. Sehested et al. JAMA Cardiology
- Tissue-specific epigenetics of atherosclerosis-related ANGPT and ANGPTL genes
- (2019) Kenneth C Ehrlich et al. Epigenomics
- T cell co-stimulation and co-inhibition in cardiovascular disease: a double-edged sword
- (2019) Karin H. Simons et al. Nature Reviews Cardiology
- Evidence-Based Cardiovascular Risk Management in Diabetes
- (2019) Arshag D. Mooradian American Journal of Cardiovascular Drugs
- OUP accepted manuscript
- (2018) EUROPEAN HEART JOURNAL
- Immune modulatory effects of statins
- (2018) Robert Zeiser IMMUNOLOGY
- Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases
- (2018) Aikaterini Arida et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus
- (2018) Naoto Katakami Journal of Atherosclerosis and Thrombosis
- Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
- (2018) Paul M Ridker et al. LANCET
- Statins Therapy for Connective Tissue Diseases: New Therapeutic Opportunities
- (2018) Przemyslaw J. Kotyla et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Inflammation: the new cardiovascular risk factor
- (2018) Thomas F Lüscher EUROPEAN HEART JOURNAL
- The role of B cells in atherosclerosis
- (2018) Andrew P. Sage et al. Nature Reviews Cardiology
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
- (2018) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Monocyte and haematopoietic progenitor reprogramming as common mechanism underlying chronic inflammatory and cardiovascular diseases
- (2017) Renate M Hoogeveen et al. EUROPEAN HEART JOURNAL
- HIV-1–Associated Atherosclerosis
- (2017) Alison Kearns et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Interleukin-1 Beta as a Target for Atherosclerosis Therapy
- (2017) Peter Libby JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The NLRP3 inflammasome in acute myocardial infarction
- (2017) Stefano Toldo et al. Nature Reviews Cardiology
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epigenetics of Atherosclerosis: Emerging Mechanisms and Methods
- (2017) Nadiya Khyzha et al. TRENDS IN MOLECULAR MEDICINE
- Genetic and Epigenetic Determinants in Autoinflammatory Diseases
- (2017) Damiana Álvarez-Errico et al. Frontiers in Immunology
- Effect of monoclonal antibodies to PCSK9 on high-sensitivity C-reactive protein levels: a meta-analysis of 16 randomized controlled treatment arms
- (2016) Amirhossein Sahebkar et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering
- (2016) Giuseppe Danilo Norata et al. CARDIOVASCULAR RESEARCH
- From C-Reactive Protein to Interleukin-6 to Interleukin-1
- (2016) Paul M Ridker CIRCULATION RESEARCH
- Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial
- (2016) Ola Kleveland et al. EUROPEAN HEART JOURNAL
- Circulating Levels of IL‐6 Receptor and gp130 and Long‐Term Clinical Outcomes in ST‐Elevation Myocardial Infarction
- (2016) Vibeke N. Ritschel et al. Journal of the American Heart Association
- START or SMART? Timing of Antiretroviral Therapy Initiation and Cardiovascular Risk for People With Human Immunodeficiency Virus Infection
- (2016) Mark J. Siedner Open Forum Infectious Diseases
- PCSK9 Induces CD36 Degradation and Affects Long-Chain Fatty Acid Uptake and Triglyceride Metabolism in Adipocytes and in Mouse LiverSignificance
- (2015) Annie Demers et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-ITCLINICAL PERSPECTIVES
- (2015) Erin A. Bohula et al. CIRCULATION
- Flow-dependent epigenetic DNA methylation regulates endothelial gene expression and atherosclerosis
- (2014) Jessilyn Dunn et al. JOURNAL OF CLINICAL INVESTIGATION
- Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
- (2014) Colette J Smith et al. LANCET
- The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia–reperfusion injury
- (2013) Øystein Sandanger et al. CARDIOVASCULAR RESEARCH
- Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis
- (2013) Roland Klingenberg et al. JOURNAL OF CLINICAL INVESTIGATION
- Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
- (2012) Hye-Mi Lee et al. DIABETES
- Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
- (2012) Stefan M. Nidorf et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
- (2012) LANCET
- Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels
- (2011) Nicola Ferri et al. ATHEROSCLEROSIS
- Comparative assessment of vascular function in autoimmune rheumatic diseases: Considerations of prevention and treatment
- (2011) Pál Soltész et al. AUTOIMMUNITY REVIEWS
- Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
- (2011) C. A. Dinarello BLOOD
- Inflammasome Activation of Cardiac Fibroblasts Is Essential for Myocardial Ischemia/Reperfusion Injury
- (2011) Masanori Kawaguchi et al. CIRCULATION
- Immunology in clinic review series; focus on autoinflammatory diseases: role of inflammasomes in autoinflammatory syndromes
- (2011) V. U. Ozkurede et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Relation of Baseline High-Sensitivity C-Reactive Protein Level to Cardiovascular Outcomes With Rosuvastatin in the Justification for Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)
- (2010) Paul M. Ridker et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet
- (2010) D. C. Chan et al. DIABETES CARE
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid-lowering effect
- (2009) D Gómez-Garre et al. BRITISH JOURNAL OF PHARMACOLOGY
- Induction of the Cytoprotective Enzyme Heme Oxygenase-1 by Statins Is Enhanced in Vascular Endothelium Exposed to Laminar Shear Stress and Impaired by Disturbed Flow
- (2009) Faisal Ali et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial
- (2009) Paul M Ridker et al. LANCET
- CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
- (2009) Cameron R Stewart et al. NATURE IMMUNOLOGY
- A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism
- (2009) Robert J. Glynn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Association of C-Reactive Protein and CRP Genotype with Coronary Heart Disease: Findings from Five Studies with 4,610 Cases amongst 18,637 Participants
- (2008) Debbie A. Lawlor et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started